Home LiteratureArticle Details
PMID: 20565864 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns.

Breast cancer research : BCR ·Vol. 12 ·No. 3 ·2010-00-00 ·Pages R36

Holm K, Hegardt C, Staaf J, Vallon-Christersson J, Jönsson G, Olsson H, Borg A, Ringnér M

Abstract

Five different molecular subtypes of breast cancer have been identified through gene expression profiling. Each subtype has a characteristic expression pattern suggested to partly depend on cellular origin. We aimed to investigate whether the molecular subtypes also display distinct methylation profiles. We analysed methylation status of 807 cancer-related genes in 189 fresh frozen primary breast tumours and four normal breast tissue samples using an array-based methylation assay. Unsupervised analysis revealed three groups of breast cancer with characteristic methylation patterns. The three groups were associated with the luminal A, luminal B and basal-like molecular subtypes of breast cancer, respectively, whereas cancers of the HER2-enriched and normal-like subtypes were distributed among the three groups. The methylation frequencies were significantly different between subtypes, with luminal B and basal-like tumours being most and least frequently methylated, respectively. Moreover, targets of the polycomb repressor complex in breast cancer and embryonic stem cells were more methylated in luminal B tumours than in other tumours. BRCA2-mutated tumours had a particularly high degree of methylation. Finally, by utilizing gene expression data, we observed that a large fraction of genes reported as having subtype-specific expression patterns might be regulated through methylation. We have found that breast cancers of the basal-like, luminal A and luminal B molecular subtypes harbour specific methylation profiles. Our results suggest that methylation may play an important role in the development of breast cancers.

MeSH Terms
Breast/metabolism,pathology Breast Neoplasms/classification,genetics,pathology CpG Islands DNA Methylation DNA, Neoplasm/genetics Female Gene Dosage Genes, BRCA1 Genes, BRCA2 Humans Middle Aged Mutation/genetics Neoplasms, Basal Cell/classification,genetics,pathology Oligonucleotide Array Sequence Analysis Polymerase Chain Reaction Prognosis Promoter Regions, Genetic/genetics Survival Rate
Chemicals
DNA, Neoplasm
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Holm Karolina
Department of Oncology, Clinical Sciences, Lund University, Barngatan 2B, Lund, Sweden. [email protected]
Hegardt Cecilia
Staaf Johan
Vallon-Christersson Johan
Jönsson Göran
Olsson Håkan
Borg Ake
Ringnér Markus
References (46)
46 references, click to expand
  1. Array-based DNA methylation profiling in follicular lymphoma.
    Leukemia. 2009 Oct;23(10):1858-66 PMID: 19587707
  2. High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.
    Breast Cancer Res. 2010;12(3):R25 PMID: 20459607
  3. Control of developmental regulators by Polycomb in human embryonic stem cells.
    Cell. 2006 Apr 21;125(2):301-13 PMID: 16630818
  4. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing.
    Nat Genet. 2007 Feb;39(2):237-42 PMID: 17211412
  5. Supervised risk predictor of breast cancer based on intrinsic subtypes.
    J Clin Oncol. 2009 Mar 10;27(8):1160-7 PMID: 19204204
  6. Relevance of DNA methylation in the management of cancer.
    Lancet Oncol. 2003 Jun;4(6):351-8 PMID: 12788407
  7. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
    Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74 PMID: 11553815
  8. Significance analysis of microarrays applied to the ionizing radiation response.
    Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21 PMID: 11309499
  9. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling.
    Blood. 2009 Mar 12;113(11):2488-97 PMID: 19075189
  10. Suz12 binds to silenced regions of the genome in a cell-type-specific manner.
    Genome Res. 2006 Jul;16(7):890-900 PMID: 16751344
  11. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.
    Nat Genet. 2010 Feb;42(2):181-5 PMID: 20081860
  12. Polycomb group protein ezh2 controls actin polymerization and cell signaling.
    Cell. 2005 May 6;121(3):425-36 PMID: 15882624
  13. Genetic alterations and oncogenic pathways associated with breast cancer subtypes.
    Mol Cancer Res. 2009 Apr;7(4):511-22 PMID: 19372580
  14. A gene hypermethylation profile of human cancer.
    Cancer Res. 2001 Apr 15;61(8):3225-9 PMID: 11309270
  15. Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.
    Semin Cancer Biol. 2009 Jun;19(3):165-71 PMID: 19429480
  16. Stem cells and cancer; the polycomb connection.
    Cell. 2004 Aug 20;118(4):409-18 PMID: 15315754
  17. The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
    Breast Cancer Res. 2008;10(3):R53 PMID: 18559090
  18. Evidence for an instructive mechanism of de novo methylation in cancer cells.
    Nat Genet. 2006 Feb;38(2):149-53 PMID: 16444255
  19. Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes.
    Clin Cancer Res. 2008 Aug 15;14(16):5158-65 PMID: 18698033
  20. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository.
    Nucleic Acids Res. 2002 Jan 1;30(1):207-10 PMID: 11752295
  21. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.
    Genes Dev. 2006 May 1;20(9):1123-36 PMID: 16618801
  22. Molecular portraits of human breast tumours.
    Nature. 2000 Aug 17;406(6797):747-52 PMID: 10963602
  23. TM4: a free, open-source system for microarray data management and analysis.
    Biotechniques. 2003 Feb;34(2):374-8 PMID: 12613259
  24. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis.
    Nature. 2010 Apr 15;464(7291):1071-6 PMID: 20393566
  25. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells.
    Genes Dev. 2007 May 1;21(9):1050-63 PMID: 17437993
  26. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.
    Nat Med. 2009 Aug;15(8):907-13 PMID: 19648928
  27. Polycomb silencers control cell fate, development and cancer.
    Nat Rev Cancer. 2006 Nov;6(11):846-56 PMID: 17060944
  28. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer.
    Nat Genet. 2009 May;41(5):521-3 PMID: 19330029
  29. The Polycomb group protein EZH2 directly controls DNA methylation.
    Nature. 2006 Feb 16;439(7078):871-4 PMID: 16357870
  30. Polycomb group proteins: navigators of lineage pathways led astray in cancer.
    Nat Rev Cancer. 2009 Nov;9(11):773-84 PMID: 19851313
  31. EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer.
    Breast Cancer Res. 2008;10(6):R109 PMID: 19099573
  32. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer.
    Nat Genet. 2007 Feb;39(2):232-6 PMID: 17200670
  33. High-throughput DNA methylation profiling using universal bead arrays.
    Genome Res. 2006 Mar;16(3):383-93 PMID: 16449502
  34. [''R"--project for statistical computing].
    Ugeskr Laeger. 2008 Jan 28;170(5):328-30 PMID: 18252159
  35. Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer.
    Ann Oncol. 2008 Nov;19(11):1870-4 PMID: 18647968
  36. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals.
    Nat Genet. 2003 Mar;33 Suppl:245-54 PMID: 12610534
  37. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
    Cancer Res. 1999 May 15;59(10):2307-12 PMID: 10344734
  38. Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.
    Breast Cancer Res. 2008;10(3):R46 PMID: 18485221
  39. Epigenetic stem cell signature in cancer.
    Nat Genet. 2007 Feb;39(2):157-8 PMID: 17200673
  40. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
    Genes Chromosomes Cancer. 2007 Jun;46(6):543-58 PMID: 17334996
  41. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.
    Nat Genet. 2008 May;40(5):499-507 PMID: 18443585
  42. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
    Breast Cancer Res. 2010;12(3):R42 PMID: 20576095
  43. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
    Nat Genet. 2008 Jun;40(6):741-50 PMID: 18488029
  44. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
    Cancer Cell. 2006 Dec;10(6):529-41 PMID: 17157792
  45. Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.
    J Clin Oncol. 2010 Apr 10;28(11):1813-20 PMID: 20231686
  46. The molecular portraits of breast tumors are conserved across microarray platforms.
    BMC Genomics. 2006 Apr 27;7:96 PMID: 16643655
Article Info
Journal
Breast cancer research : BCR
Abbr.
Breast Cancer Res
ISSN
1465-542X
Published
2010-00-00
Epub
2010-00-18
Pages
R36
Language
English
Region
England
NLM ID
100927353
PMCID
PMC2917031
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]